Recent Finacing
Recent Raise
Polyphor is a Basel-based clinical-stage specialty pharmaceutical company developing macrocycle therapeutics for antibiotic-resistant Gram-negative infections and severe respiratory and oncology indications, advancing Murepavadin, POL6014, and balixafortide.
